U.S. Pharmacist Vaccine Update
December 2019

Few Serious Adult Adverse Reactions With MMR Vaccine
Adults receiving the mumps, measles, and rubella (MMR) vaccine have extremely low rates of serious adverse reactions, according to a new study looking at nearly 150,000 reports to the Vaccine Safety Datalink. Find out why that might be the case and how the outcomes differed by age.

Advertisement


Zoster Vaccine Safe for Patients Using TNFi Therapy
Many patients with rheumatic disease are immunocompromised because of treatment with tumor necrosis factor inhibitor (TNFi) therapy and low-dose glucocorticoids. A new study determines, however, that they don't need to avoid receiving the live zoster virus vaccine to protect against shingles. Here is more information.

How Valuable Are Vaccines for Postexposure and Prevention?
Prevention is usually what comes to mind when pharmacists think about vaccines. But some types, rabies and smallpox, also have had postexposure benefits. Now, a new systematic review suggests that could be the case for a range of vaccine types. Here are more details.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App

Advertisement[timestamp];dc_lat=;dc_rdid=;tag_for_child_directed_treatment=;tfua=?" height="1" width="1" alt="Advertisement" style="border-width: 0px; border-style: solid;" />